Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Nirsevimab (Beyfortus), an antibody targeting respiratory syncytial virus (RSV), is indicated for newborns and infants to prevent bronchiolitis. Available since September 2023, its widespread use may ...

In a recent study published in the bioRxiv* preprint server, researchers at the Medical University of Innsbruck assessed the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3CLpro ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

The virus that causes COVID-19 might be becoming resistant to antiviral treatments, new research has warned. But should we be concerned? The antiviral drugs nirmatrelvir and remdesivir are recommended ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

A study published in Nature Medicine found that monkeypox viruses from the current outbreak have on average 50 differences in their DNA compared to the versions from about four years earlier. That’s ...

Tamiflu, the same antiviral used to treat ordinary seasonal influenza, is the front line medication recommended for treating highly pathogenic bird flu (Photo by Rui Vieira/PA Images via Getty Images) ...